Observational study / 2009
Myosmine levels in toenails, saliva, and plasma differed modestly between smokers and non-smokers, indicating non-tobacco sources contribute to exposure.
Analytical GC/MS methods were developed to measure myosmine, nicotine, and cotinine in toenails, saliva, and plasma to monitor exposure. In 14 smokers and 10 non-smokers, myosmine differed by smoking status in toenails (66 +/- 56 vs 21 +/- 15 ng/g, p <0.01) and saliva (2.54 +/- 2.68 vs 0.73 +/- 0.65 ng/ml, p <0.01), but differences were far smaller than for nicotine or cotinine. In plasma from 84 endoscopy patients, differences between 25 smokers and 59 non-smokers remained small for myosmine (0.30 +/- 0.35 vs 0.16 +/- 0.18 ng/ml, p <0.05) compared to cotinine (54.67 +/- 29.63 vs 0.61 +/- 1.82 ng/ml, p <0.0001). The authors concluded that non-tobacco sources contribute considerably to the human body burden of myosmine.
Shows an association, not proof of cause and effect.
- Study type
- Cross-sectional biomonitoring validation study
- Who was studied
- 14 smokers and 10 non-smokers, plus 84 endoscopy patients (25 smokers, 59 non-smokers)
- What was measured
- Levels of myosmine, nicotine, and cotinine in toenails, saliva, and plasma
THE PAPER
Analysis of myosmine, cotinine and nicotine in human toenail, plasma and saliva.
Schütte-Borkovec K, Heppel CW, Heling AK, Richter E. Biomarkers, 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.